Weiss Multi-Strategy Advisers LLC - LYELL IMMUNOPHARMA INC ownership

LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 53 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 2.2%.

Quarter-by-quarter ownership
Weiss Multi-Strategy Advisers LLC ownership history of LYELL IMMUNOPHARMA INC
ValueSharesWeighting
Q3 2021$218,000
-46.3%
14,700
-41.2%
0.01%
-44.4%
Q2 2021$406,00025,0000.01%
Other shareholders
LYELL IMMUNOPHARMA INC shareholders Q2 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 20,162,332$156,056,00045.49%
Foresite Capital Management IV, LLC 13,282,181$102,804,00021.15%
Apoletto Ltd 15,093,969$116,827,00014.55%
SB Management Ltd 3,500,000$27,090,0002.68%
HSG Holding Ltd 3,045,997$23,576,0002.11%
MIC Capital Management UK LLP 1,320,000$10,217,0001.95%
Alphabet Inc. 5,865,125$45,396,0001.10%
Board of Trustees of The Leland Stanford Junior University 1,647,882$12,754,0000.80%
Adero Partners, LLC 491,372$3,803,0000.62%
Ergoteles LLC 1,008,428$7,805,0000.30%
View complete list of LYELL IMMUNOPHARMA INC shareholders